Navigation Links
FASEB SRC announces conference: Matricellular Proteins in Development, Health, and Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Matricellular Proteins in Development, Health, and Disease.

Interactions between cells and their surrounding extracellular matrix (ECM) are the basis for multi-cellular life and essential for cell and tissue organization in all metazoan organisms. Structural ECM components such as collagens, fibronectin, and laminins, are secreted by cells and assembled extracellularly into organized sheets (basement membranes) or three-dimensional fibrils and networks (connective tissue matrix). ECM also contains less abundant, but highly regulated, components that play important roles in controlling cell behavior and matrix remodeling. Because of their distinctive localizations and functional attributes in the ECM, these proteins have been termed matricellular proteins and include members of the thrombospondin, CCN, tenascin, osteopontin, periostin, fibulin, and SPARC families.

The purpose of this conference is to focus on these matricellular proteins and to examine their structure-function relationships and their impact on signaling networks that play key roles in disease, homeostasis, repair, and development. The conference format includes lectures and poster sessions and short talks selected from submitted abstracts and late breaking work. The program covers both mechanistic scientific perspectives (Sessions 1-3) and disease specific emphases (Sessions 4-9). Mechanistic sessions will discuss novel regulatory mechanisms of the matricellular proteins and their receptors (Session 1) and the complex roles of matricellular proteins in regulation of multiple growth factors in disease (Session 3), which is an important function of these proteins in homeostasis and disease.

For the first time, we will have a session to highlight mammalian and non-mammalian model systems (Session 2). The long-standing disease focus areas of the field in cardiovascular disease (Session 6), carcinogenesis/angiogenesis (Session 7), and in musculoskeletal development and disease (Session 9) are well represented on the program. In addition, there will be three sessions focusing on emerging areas of intense activity and significant progress in the matricellular field over the past two-three years: inflammation and immunity (Session 4), diabetes and obesity (Session 5), and neurobiology (synapse formation, neuropathic pain) (Session 8).

Inclusion of women, minorities, and young scientists has been emphasized in developing the program. Invited speakers represent leaders in the basic sciences, clinical investigators who are defining the roles of matricellular proteins in the etiology of inherited disorders and several major diseases of adults, and investigators developing novel therapeutics to treat these diseases. The overall objectives of this meeting are to foster new knowledge in the field of matricellular proteins that will lead to development of therapeutics for the treatment of human diseases, facilitate the development of new multidisciplinary collaborations and research directions, and encourage the development of young scientists in this field.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB SRC announces conference registration open for: Biology and Chemistry of Vision
2. FASEB SRC announces conference registration open for: Hematologic Malignancies
3. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
4. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
5. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
6. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
7. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
8. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
9. FASEB urges biomedical research community to speak out against sequestration
10. FASEB lauds Air India for transporting research animals
11. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: